The prototypic Th2 autoimmunity induced by mercury is dependent on IFN- γ and not Th1/Th2 imbalance

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 234-240

  Kono, Dwight H ^a   Balomenos, Dimitri ^a   Pearson, Deborah L ^a   Park, Miyo S ^a   Hildebrandt, Bernhard ^a   Hultman, Per ^b   Michael Pollard, K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 4; MERCURY;

ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HELPER CELL; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; IMMUNOHISTOLOGY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HAPTENS; INTERFERON TYPE II; INTERLEUKIN-4; MERCURIC CHLORIDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITROPHENOLS; TH1 CELLS; TH2 CELLS;

EID: 0031859079     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
2. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
3. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.
4. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
5. Zheng, W., and R. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
6. Pernis, A., S. Gupta, K. J. Gollob, E. Garfein, R. L. Coffman, C. Schindler, and P. Rothman. 1995. Lack of interferon-γ receptor β chain and the prevention of interferon-γ signaling in Th1 cells. Science 269:245.
7. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human helper 2 cells. Science 277:2005.
8. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
9. Gorham, J. D., M. L. Guler, R. G. Steen, A. J. Mackey, M. J. Daly, K. Frederick, W. F. Dietrich, and K. M. Murphy. 1996. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93:12467.
10. + T cells. Annu. Rev. Immunol. 12:635.
11. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
12. Romagnani, S. 1996. Short analytical review: TH1 and TH2 in human diseases. Clin. Immunol. Immunopathol. 80:225.
13. Charlton, B., and K. J. Lafferty. 1995. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7:793.
14. Kroemer, G., F. Hirsch, A. Gonzalez-Garcia, and C. Martinez. 1996. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24:25.
15. H2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12:223.
16. Mathieson, P. W. 1995. Mercury: god of Th2 cells? Clin. Exp. Immunol. 102:229.
17. Pollard, K. M., and P. Hultman. 1997. Effects of mercury on the immune system. In Metal Ions in Biological Systems. A. Sigel and H. Sigel, eds. Marcel Dekker, Inc., New York, p. 421.
18. Pelletier, L., R. Pasquier, J. Ressert, M. C. Vial, C. Mandet, and P. Druet. 1988. Autoreactive T cells in mercury-induced autoimmunity: ability to induce the autoimmune disease. J. Immunol. 140:750.
19. Biancone, L., G. Andres, H. Ahn, A. Lim, C. Dai, R. Noelle, H. Yagita, C. DeMartino, and I. Stamenkovic. 1996. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated autoimmune disease. J. Exp. Med. 183:1473.
20. Hultman, P., L. J. Bell, S. Enestrom, and K. M. Pollard. 1993. Murine susceptibility to mercury. II. Autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin. Immunol. Immunopathol. 68:9.
21. Ochel, M., H. W. Vohr, C. Pfeiffer, and E. Gleichmann. 1991. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J. Immunol. 146:3006.
22. Prigent, P., A. Saoudi, C. Pannetier, P. Graber, J. Y. Bonnefoy, P. Druet, and F. Hirsch. 1995. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4. J. Clin. Invest. 96:1484.
23. Gillespie, K. M., A. Saoudi, J. Kuhn, C. J. Whittle, P. Druet, B. Blanche, and P. W. Mathieson. 1996. Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur. J. Immunol. 26:2388.
24. Castedo, M., L. Pelletier, R. Pasquier, and P. Druet. 1994. Improvement of TH1 functions during the regulation phase of mercury disease in brown Norway rats. Scand. J. Immunol. 39:144.
25. Van der Meide, P. H., R. J. Groenestein, M. C. de Labie, J. Aten, and J. J. Weening. 1995. Susceptibility to mercuric chloride-induced glomerulone-phritis is age-dependent: study of the role of IFN-γ. Cell. Immunol. 162:131.
26. high T cells in mercury-induced autoimmunity in the brown Norway rat. J. Exp. Med. 177:1309.
27. Saoudi, A., J. Kuhn, K. Huygen, Y. de Kozak, T. Velu, M. Goldman, P. Druet, and B. Bellon. 1993. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 23:3096.
28. Levine, S., and A. Saltzman. 1989. Suppression of experimental allergic encephalomyelitis in rats by mercuric chloride. Chem. Biol. Interact. 69:17.
29. Druet, P., and L. Pelletier. 1996. Th2 and Th1 autoreactive anti-class II cell lines in the rat suppress or induce autoimmunity. J. Autoimmun. 9:221.
30. d mice is mediated by interferon-γ (IFN-γ). Clin. Exp. Immunol. 109:149.
31. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-γ mRNA in the lymph nodes of lupusprone mice. Mol. Immunol. 32:495.
32. Takahashi, S., L. Fossati, I. Iwamoto, J. Merino, R. Motta, T. Kobayakawa, and S. Izui, 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597.
33. 1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 166:198.
34. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25:6.
35. Santiago, M., L. Fossati, C. Jacquiet, W. Muller, S. Izui, and L. Reininger. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185:65.
36. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936.
37. Haas, C., B. Ryffel, and H. M. Le. 1997. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J. Immunol. 158:5484.
38. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
39. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
40. Takeuchi, K., S. J. Turley, E. M. Tan, and K. M. Pollard. 1995. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J. Immunol. 154:961.
41. Burlingame, R. W., R. L. Rubin, R. S. Balderas, and A. N. Theofilopoulos. 1993. The genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687.
42. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
43. Bell, S. A., M. V. Hobbs, and R. L. Rubin. 1992. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J. Immunol. 148:3369.
44. Turley, S. J., E. M. Tan, and K. M. Pollard. 1993. Molecular cloning and sequence analysis of U3 snoRNA-associated mouse fibrillarin. Biochim. Biophys. Acta 1216:119.
45. Hultman, P., and S. Enestrom. 1992. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol. Appl. Pharmacol. 113:199.
46. Van Vliet, E., M. Uhrberg, C. Stein, and E. Gleichmann. 1993. MHC control of IL-4-dependent enhancement of B cell Ia expression and Ig class switching in mice treated with mercuric chloride. Int. Arch. Allergy Immunol. 101:392.
47. Huang, S., W. Hendricks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, and R. M. Zinkemagel. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
48. Graham, M. D., D. K. Dalton, D. Giltinan, V. L. Braciale, T. A. Stewart, and T. J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon-γ gene. J. Exp. Med. 178:1725.
49. Schijns, V. E., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet, and M. C. Horzinek. 1994. IFN-γ receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153:2029.
50. Marion, T. N., D. M. Tillman, N. T. Jou, and R. J. Hill. 1992. Selection of immunoglobulin variable regions in autoimmunity to DNA. Immunol. Rev. 128:123.
51. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101:364.
52. Balasa, B., C. Deng, J. Lee, L. M. Bradley, D. K. Dalton, P. Christadoss, and N. Sarvetnick. 1997. Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice. J. Exp. Med. 186:385.
53. Von Herrath, M. G., and M. B. A. Oldstone. 1997. Interferon-gamma is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531.
54. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathmann. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
55. Jones, L. S., L. V. Rizzo, R. K. Agarwal, T. K. Tarrant, C. C. Chan, B. Wiggert, and R. R. Caspi. 1997. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158:5997.
56. Manoury-Schwartz, B., G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, S. Muller, S. Huang, M. C. Boissier, and C. Fournier. 1997. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158:5501.
57. Vermeire, K., H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys. 1997. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol. 158:5507.
58. Hultgren, B., X. Huang, N. Dybdal, and T. A. Stewart. 1996. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812.
59. Kopf, M., G. LeGros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
60. . 60. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
61. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
62. Kuhn, R., and F. Schwenk. 1997. Advances in gene targeting methods. Curr. Opin. Immunol. 9:183.
63. Allen, J. E., and R. M. Maizels. 1997. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today 18:387.
64. Strom, T. B., P. Roy-Chaudhury, R. Manfro, X. X. Zheng, P. W. Nickerson, K. Wood, and A. Bushell. 1996. The Th1/Th2 paradigm and the allograft response. Curr. Opin. Immunol. 8:688.
65. Piccotti, J. R., S. Y. Chan, A. M. VanBuskirk, E. J. Eichwald, and D. K. Bishop. 1997. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 63:619.
66. Goodnow, C. C., J. G. Cyster, S. B. Hartley, S. E. Bell, M. P. Cooke, J. I. Healy, S. Akkaraju, J. C. Rathmell, S. L. Pogue, and K. P. Shokat. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59:279.
67. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93:2260.